The Pathogenesis of Nonalcoholic Steatohepatitis and Other Fatty Liver Diseases: A Four-Step Model including the Role of Lipid Release and Hepatic Venular Obstruction in the Progression to Cirrhosis

Seminars in Liver Disease

Volumn 24, Issue 1, 2004, Pages 99-106

  Wanless, Ian R ^a   Shiota, Koji ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Alcohol; Jejunoileal bypass; Lipopeliosis; NAFLD; NASH; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Steatohepatitis; Steatosis; Transplantation

Indexed keywords

ALCOHOL; DRUG; INSULIN; TRIACYLGLYCEROL;

ARTICLE; COLLATERAL CIRCULATION; DISEASE COURSE; DISEASE MODEL; FAT NECROSIS; FATTY LIVER; HUMAN; HUMAN TISSUE; INFLAMMATION; ISCHEMIA; JEJUNOILEAL BYPASS; LIPID PEROXIDATION; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NECROSIS; LIVER TRANSPLANTATION; LIVER VEIN; LIVER VEIN OBSTRUCTION; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; VENULE;

BIOPSY; FATTY LIVER; HEPATIC VEINS; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; LIPIDS; LIVER; LIVER CIRRHOSIS; MODELS, BIOLOGICAL; NECROSIS;

EID: 1942423097     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-823104     Document Type: Article

References (30)

1. Wanless IR, Bargman JM, Oreopoulos DG, Vas SI. Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity. Mod Pathol 1989;2:69-74
2. Woodside WF, Heimberg M. The metabolism of oleic acid by the perfused rat liver in experimental diabetes induced by antiinsulin serum. Metabolism 1978;27:1763-1777
3. Sohn J, Siegelman E, Osiason A. Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. AJR Am J Roentgenol 2001;176: 471-474
4. Battaglia DM, Wanless IR, Brady AP, Mackenzie RL. Intrahepatic sequestered segment of liver presenting as focal fatty change. Am J Gastroenterol 1995;90:2238-2239
5. Redston M, Wanless IR. The effect of insulin on development of fatty liver in choline deficient rats. Mod Pathol 1991;4:95A
6. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12:1106-1110
7. King EG, Nakane PK, Ashbaugh DG. The canine oleic acid model of fibrin localization in fat embolism. Surgery 1971; 69:782-787
8. Mavrelis PG, Ammon HV, Gleysteen JJ, Komorowski RA, Charaf UK. Hepatic free fatty acids in alcoholic liver disease and morbid obesity. Hepatology 1983;3:226-231
9. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-845
10. Caldwell SH, Swerdlow RH, Khan EM, et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol 1999;31:430-434
11. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120: 1183-1192
12. Diehl AM. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 2002;282:G1-G5
13. Videla LA, Rodrigo R, Orellana M, et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci (Lond) 2003;103:261-268
14. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-1219
15. Wanless IR, Sweeney G, Dhillon AP, et al. Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia. Blood 2002;100:1566-1569
16. Cha I, Bass N, Ferrell LD. Lipopeliosis. An immunohistochemical and clinicopathologic study of five cases. Am J Surg Pathol 1994;18:789-795
17. Edmondson HA, Peters RL, Reynolds TB, Kuzma OT. Sclerosing hyaline necrosis of the liver in the chronic alcoholic. a recognizable clinical syndrome. Ann Intern Med 1963;59:646-673
18. Edmondson HA, Peters RL, Frankel HH, Borowsky S. The early stage of liver injury in the alcoholic. Medicine (Baltimore) 1967;46:119-129
19. Brunt EM, Tiniakos DG. Pathology of steatohepatitis. Best Pract Res Clin Gastroenterol 2002;16:691-707
20. Goodman ZD, Ishak KG. Occlusive venous lesions in alcoholic liver disease. A study of 200 cases. Gastroenterology 1982;83:786-796
21. Nakanuma Y, Ohta G, Doishita K. Quantitation and serial section observations of focal veno-occlusive lesions of hepatic veins in liver cirrhosis. Virchows Arch A Pathol Anat Histopathol 1985;405:429-438
22. Burt AD, MacSween RN. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study. J Clin Pathol 1986;39:63-67
23. Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 2000;124:1599-1607
24. Rimarenko S, Jagirdar J. Veno-occlusive syndrome of the liver in an alcoholic man. Mt Sinai J Med 1984;51:292-294
25. Wanless IR. Vascular disorders. In: Macsween RNM, Burt AD, Portmann BC, eds. Pathology of the Liver, 4th ed. Edinburgh: Churchill Livingstone; 2002:539-574
26. Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998;27:488-496
27. Wanless IR, Shiota K, Heathcote EJ. Role of hepatic vein obliteration in the progression of non-alcoholic steatohepatitis (NASH) to cirrhosis. Hepatology 2002;36: 730A
28. Shimamatsu K, Wanless IR. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 1997;26:343-350
29. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Dannenberg AJ. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. J Pharmacol Exp Ther 2001;299:638-644
30. Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002;16:663-678